Expedia
EXPE
258.86
-1.21
-0.47%
Expedia
US · EXPE
#650 by market cap
Listed 1970
258.86
-1.21
-0.47%
Live - 5344 symbols - heartbeat 111s ago
· 2026-10-08 06:12
Pre-market
259.88
+0.39%
After-hours
258.86
0.00%
Overnight
258.58
-0.11%
- Market cap
- 31.07B
- P/E (TTM)i
- 16.28
- P/Bi
- 25.70
- EPSi
- 9.81
- Div yieldi
- 0.68%
- 52W posi
- 47%
Reader sentiment
Are you bullish or bearish on EXPE?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.62, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +7.61% YoY
Margins
- Gross margin
- 90.12%
- Operating margin
- 14.68%
- Net margin
- 8.78%
Key ratios & quality
- Enterprise valuei
- 31.50B
- PEG ratioi
- 0.30
- Altman Z-Scorei
- 1.62
PEG uses trailing P/E against the 3-year net income growth rate (54.33%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 11.22B | 12.07B | 5.20B | 8.60B | 11.67B | 12.84B | 13.69B | 14.73B |
| Gross profit | 9.36B | 10.00B | 3.55B | 7.08B | 10.01B | 11.27B | 12.25B | 13.28B |
| Selling & admin expenses | 6.50B | 6.87B | 3.12B | 4.93B | 6.85B | 7.63B | 8.43B | 8.95B |
| Research & development | 1.12B | 1.26B | 1.07B | 1.07B | 1.18B | 1.36B | 1.31B | 1.28B |
| Operating profit | 783.00M | 961.00M | -1.53B | 262.00M | 1.19B | 1.53B | 1.67B | 2.16B |
| Pretax profit | 485.00M | 775.00M | -3.15B | -38.00M | 538.00M | 1.02B | 1.54B | 1.59B |
| Tax | 87.00M | 203.00M | -423.00M | -53.00M | 195.00M | 330.00M | 318.00M | 290.00M |
| Net profit | 398.00M | 572.00M | -2.73B | 15.00M | 343.00M | 688.00M | 1.22B | 1.30B |
| Basic EPS | 3 | 4 | -19 | -2 | 2 | 6 | 9 | 10 |
| Diluted EPS | 2.65 | 3.77 | -19.00 | -1.80 | 2.17 | 5.31 | 8.95 | 9.81 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 2.99B | 3.79B | 4.41B | 3.55B | 3.43B | 4.32B |
| Gross profit | 2.63B | 3.41B | 4.04B | 3.20B | 3.05B | 3.91B |
| Selling & admin expenses | 2.14B | 2.33B | 2.37B | 2.11B | 2.25B | 2.54B |
| Research & development | 320.00M | 325.00M | 310.00M | 322.00M | 324.00M | 325.00M |
| Operating profit | -44.00M | 531.00M | 1.13B | 548.00M | 243.00M | 819.00M |
| Pretax profit | -217.00M | 423.00M | 1.13B | 254.00M | 25.00M | 1.03B |
| Tax | -20.00M | 101.00M | 167.00M | 42.00M | 37.00M | 152.00M |
| Net profit | -197.00M | 322.00M | 964.00M | 212.00M | -12.00M | 875.00M |
| Basic EPS | -2 | 3 | 8 | 2 | 0 | 7 |
| Diluted EPS | -1.56 | 2.48 | 7.33 | 1.60 | -0.05 | 7.16 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 5.20B | 7.74B | 5.63B | 8.18B | 8.79B | 9.23B | 9.82B | 12.20B |
| Cash & ST investments | 2.47B | 3.84B | 3.39B | 4.31B | 4.14B | 4.25B | 4.48B | 5.73B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 18.03B | 21.42B | 18.69B | 21.55B | 21.56B | 21.64B | 22.39B | 24.45B |
| Total current liabilities | 8.06B | 10.71B | 5.41B | 9.45B | 10.78B | 11.78B | 13.61B | 16.66B |
| Short-term debt | -- | 749.00M | -- | 735.00M | -- | -- | 1.04B | 1.69B |
| Long-term debt | 3.72B | 4.19B | 8.22B | 7.72B | 6.24B | 6.25B | 5.22B | 4.47B |
| Total liabilities | 12,352,000,000.00 | 15,880,000,000.00 | 14,664,000,000.00 | 17,996,000,000.00 | 17,833,000,000.00 | 18,856,000,000.00 | 19,589,000,000.00 | 21,905,000,000.00 |
| Total equity | 5.68B | 5.54B | 4.03B | 3.55B | 3.73B | 2.79B | 2.80B | 2.55B |
| Retained earnings | 517.00M | 879.00M | -1.78B | -1.76B | -1.41B | -632.00M | 602.00M | 1.70B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 13.59B | 14.73B | 12.85B | 12.20B | 14.15B | 16.30B |
| Cash & ST investments | 6.13B | 6.67B | 6.17B | 5.73B | 5.79B | 7.13B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 26.11B | 26.98B | 25.11B | 24.45B | 26.46B | 29.06B |
| Total current liabilities | 18.57B | 19.61B | 17.26B | 16.66B | 19.36B | 20.35B |
| Short-term debt | 1.75B | 1.75B | 1.75B | 1.69B | -- | -- |
| Long-term debt | 4.47B | 4.47B | 4.47B | 4.47B | 4.47B | 5.46B |
| Total liabilities | 23,793,000,000.00 | 24,890,000,000.00 | 22,515,000,000.00 | 21,905,000,000.00 | 24,623,000,000.00 | 26,590,000,000.00 |
| Total equity | 2.32B | 2.09B | 2.59B | 2.55B | 1.84B | 2.47B |
| Retained earnings | 351.00M | 630.00M | 1.54B | 1.70B | 1.63B | 2.45B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.98B | 2.77B | -3.83B | 3.75B | 3.44B | 2.69B | 3.09B | 3.88B |
| Depreciation & amortization | 1.00B | 910.00M | 893.00M | 814.00M | 792.00M | 807.00M | 838.00M | 887.00M |
| Free cash flow | 1.10B | 1.61B | -4.63B | 3.08B | 2.78B | 1.84B | 2.33B | 3.11B |
| Dividends paid | -186.00M | -195.00M | -123.00M | -67.00M | -- | 0 | 0 | -200.00M |
| Stock buybacks / issuance | -923.00M | -743.00M | -425.00M | -165.00M | -607.00M | -2.14B | -1.84B | -1.93B |
| Ending cash balance | 2.71B | 4.10B | 4.14B | 5.81B | 5.85B | 5.66B | 5.57B | 6.98B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 2.95B | 1.12B | -497.00M | 304.00M | 3.93B | 1.48B |
| Depreciation & amortization | 219.00M | 223.00M | 225.00M | 220.00M | 228.00M | 228.00M |
| Free cash flow | 2.76B | 921.00M | -686.00M | 119.00M | 3.75B | 1.28B |
| Dividends paid | -51.00M | -51.00M | -49.00M | -49.00M | -58.00M | -58.00M |
| Stock buybacks / issuance | -384.00M | -688.00M | -531.00M | -327.00M | -788.00M | -270.00M |
| Ending cash balance | 7.73B | 8.46B | 7.26B | 6.98B | 7.79B | 9.08B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 9.41 | 14.00 | -98.12 | -15.08 | 16.22 | 41.76 | 79.84 | 91.09 |
| ROA %i | 2.22 | 2.86 | -13.40 | -1.34 | 1.63 | 3.69 | 5.61 | 5.53 |
| ROIC %i | 6.26 | 7.21 | -25.26 | -0.18 | 5.17 | 9.72 | 14.42 | 16.85 |
| 5-year avg ROE %i | 13.53 | 12.28 | -11.94 | -16.21 | -14.71 | -8.24 | 4.92 | 42.77 |
| EBIT margin %i | 6.01 | 7.86 | -53.68 | 3.64 | 6.99 | 9.84 | 13.06 | 12.83 |
| FCF / sales %i | 9.77 | 13.32 | -- | 35.76 | 23.81 | 14.36 | 17.01 | 21.11 |
| Current ratioi | 0.64 | 0.72 | 1.04 | 0.87 | 0.82 | 0.78 | 0.72 | 0.73 |
| Quick ratioi | 0.58 | 0.60 | 0.78 | 0.60 | 0.58 | 0.60 | 0.57 | 0.60 |
| Debt / assetsi | 20.61 | 25.54 | 46.70 | 40.89 | 30.39 | 30.34 | 29.17 | 26.24 |
| LT debt / equityi | 90.57 | 119.01 | 578.08 | 392.56 | 286.99 | 428.10 | 352.47 | 367.83 |
| Interest coveragei | 3.55 | 5.48 | -7.75 | 0.89 | 2.94 | 5.16 | 7.27 | 6.32 |
| Revenue CAGR (3Y) %i | 18.93 | 11.21 | -19.75 | -8.50 | -1.12 | 35.17 | 16.77 | 8.09 |
| Net income CAGR (3Y) %i | -19.02 | 26.07 | -- | -69.08 | -14.59 | -- | 368.50 | 54.33 |
| FCF CAGR (3Y) %i | 23.60 | 26.18 | -- | 41.00 | 20.02 | -- | -8.85 | 3.83 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 119.16 | 129.04 | 104.40 | 91.09 | 180.58 | 199.12 |
| ROA %i | 4.60 | 4.21 | 5.72 | 5.53 | 5.66 | 7.27 |
| ROIC %i | 14.01 | 15.02 | 17.62 | 16.85 | 28.20 | 33.94 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 12.49 | 11.80 | 13.31 | 12.83 | 14.40 | 17.78 |
| FCF / sales %i | 17.28 | 14.25 | 20.86 | 21.11 | 27.03 | 28.40 |
| Current ratioi | 0.73 | 0.75 | 0.74 | 0.73 | 0.73 | 0.80 |
| Quick ratioi | 0.57 | 0.59 | 0.62 | 0.60 | 0.57 | 0.64 |
| Debt / assetsi | 24.76 | 24.03 | 25.80 | 26.24 | 17.79 | 19.56 |
| LT debt / equityi | 440.39 | 566.39 | 353.78 | 367.83 | 817.01 | 470.22 |
| Interest coveragei | 7.12 | 6.92 | 7.97 | 6.32 | 6.21 | 7.86 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Business-to-customer (B2C) is the largest reported line at 62.04% of revenue, across 4 reported segments.
- Business-to-business (B2B) follows at 34.60%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Business-to-customer (B2C)62.04%
Business-to-business (B2B)34.60%
trivago4.54%
Quote time 2026-10-08 06:12:03 · For reference only, not investment advice and not tailored to your situation.